Our functional assays revealed that O6BG increased olaparib-induced DSB formation and cell apoptosis in NPC cells, supporting the therapeutic strategy of combining MGMT and PARP inhibitor in treating cancer patients. Here, MGMT is linked to nasopharyngeal carcinoma.